APA (7th ed.) Citation

Felip, E., Ghiringhelli, F., Zer, A., Cho, B. C., Lim, S. M., Greillier, L., . . . Lim, F. L. Atezolizumab and bevacizumab, with or without radiotherapy, versus docetaxel in patients with metastatic non-small cell lung cancer previously treated with a checkpoint inhibitor and chemotherapy: Results from the randomized, phase Ib/II MORPHEUS-Lung study. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Felip, Enriqueta, et al. Atezolizumab and Bevacizumab, with or Without Radiotherapy, Versus Docetaxel in Patients with Metastatic Non-small Cell Lung Cancer Previously Treated with a Checkpoint Inhibitor and Chemotherapy: Results from the Randomized, Phase Ib/II MORPHEUS-Lung Study. BMJ Publishing Group.

MLA (9th ed.) Citation

Felip, Enriqueta, et al. Atezolizumab and Bevacizumab, with or Without Radiotherapy, Versus Docetaxel in Patients with Metastatic Non-small Cell Lung Cancer Previously Treated with a Checkpoint Inhibitor and Chemotherapy: Results from the Randomized, Phase Ib/II MORPHEUS-Lung Study. BMJ Publishing Group.